Orforglipron 6MG 90 Capsules
Original price was: $239.00.$220.00Current price is: $220.00.
Orforglipron is a small-molecule compound used in research focused on metabolism, glucose control, and energy regulation. Its stable, non-peptide design allows scientists to study GLP-1 receptor activity without peptide instability concerns.
- Studied for its impact on metabolic balance and glucose regulation
- Non-peptide structure ensures stability and easy handling in research
- Useful for exploring GLP-1 receptor pathways and energy control
Size and packaging guidelines
Fermentum scelerisque hendrerit parturient nullam enim lobortis litora parturient dictumst.
Potenti a quisque tincidunt venenatis adipiscing parturient fermentum nisl tincidunt amentu.
Scelerisque conubia lobortis a condimentum ad eleifend dui integer maecenas habitant nostra.
| Specification | Chair | Armchair | Sofas |
| Height | 37" | 42" | 42" |
| Width | 26.5" | 32.5" | 142" |
| Depth | 19.5" | 22.5" | 24.5" |
| Assembly Required | No | No | Yes |
| Packaging Type | Box | Box | Box |
| Package Weight | 55 lbs. | 64 lbs. | 180 lbs. |
| Packaging Dimensions | 27" x 26" x 39" | 45" x 35" x 24" | 46" x 142" x 25" |
• Chemical Name: Orforglipron (LY-3502970)
• Molecular Formula: C₄₈H₄₈F₂N₁₀O₅ (per chemical registry data)
• Classification: Investigational small-molecule, non-peptide glucagon-like peptide-1 receptor (GLP-1R) agonist (oral)
• Mechanism of Action: Partial agonist of the GLP-1 receptor, stimulating glucose dependent insulin secretion, delaying gastric emptying, and reducing appetite to aid weight loss and glycemic control.
• Regulatory Status: Investigational (Phase III clinical trials), not yet approved by regulatory agencies such as the FDA.
• Dosage Form: Oral tablet (6 mg dose referenced in clinical studies)
• Purity: For research and clinical trial use in investigational settings, typically characterized to high analytical purity (often ≥98 % by HPLC/LC-MS — standard for clinical-phase compounds). (Exact purity specification depends on formulation batch and manufacturer analytical methods.)
• Appearance: White to off-white crystalline or microcrystalline solid/tablet (dose formulation). (Standard physical description for small-molecule pills; specific appearance can vary with excipients.)
• Pharmacokinetics (General): Oral bioavailability and half-life support once-daily dosing; phase III trials have tested 6 mg, 12 mg, and 36 mg doses.
• Clinical Effects (6 mg data context): In Phase 3 obesity studies, the 6 mg dose produced statistically significant body-weight reduction vs placebo (~7.5–7.8 % at 72 weeks) and showed gastrointestinal side effects consistent with the GLP-1 class.
Orforglipron is a research compound scientists study for its role in metabolism and blood sugar control. Its small, stable form gives steady results, helping researchers run detailed studies with precision. Because it performs reliably, scientists often use it to explore how the body manages energy and weight under controlled conditions.
Researchers study how Orforglipron interacts with GLP-1 receptors. These receptors help control hunger, energy, and insulin activity. As a result, the compound helps show how small molecules can act like peptides without using peptide-based systems. This work also expands knowledge about non-peptide methods in metabolic research.
Orforglipron’s steady structure supports clear data and consistent testing. Its oral design makes it easy to use in long studies, which helps researchers gather reliable results over time. Scientists continue to explore Orforglipron to understand its effect on metabolism and receptor function. Its stable form and dependable results make it a trusted tool for
studying metabolic balance and energy control.
Key Benefits of Orforglipron
• Supports studies on metabolic regulation and energy balance
• Helps researchers explore glucose control mechanisms
• Non-peptide design allows for improved oral bioavailability
• Offers strong stability for long-term research consistency
• Enables testing of small molecules in GLP-1 receptor pathways
• Provides reliable, repeatable data across experimental trials
• Simplifies lab handling due to its stable molecular structure
• Expands understanding of non-peptide compounds in metabolic research
Understanding Orforglipron
Understanding Orforglipron begins with its role as a small-molecule compound designed for research on metabolism and glucose control. Unlike peptide-based compounds, it offers a stable, non-peptide structure that allows scientists to explore biological responses through oral study models. This makes it a practical choice for examining energy regulation and metabolic activity in controlled settings.
Understanding Orforglipron begins with its role as a small-molecule compound designed for research on metabolism and glucose control. Unlike peptide-based compounds, it offers a stable, non-peptide structure that allows scientists to explore biological responses through oral study models. This makes it a practical choice for examining energy regulation and metabolic activity in controlled settings.
For laboratory research use only. Not for human consumption.
Key Benefits of Orforglipron
Supports studies on metabolic regulation and energy balance
Helps researchers explore glucose control mechanisms
Non-peptide design allows for improved oral bioavailability
Offers strong stability for long-term research consistency
Enables testing of small molecules in GLP-1 receptor pathways
Provides reliable, repeatable data across experimental trials
Simplifies lab handling due to its stable molecular structure
Expands understanding of non-peptide compounds in metabolic research
Orforglipron: Advancing Research in Metabolic Balance and Glucose Regulation
Orforglipron is a research compound used to study metabolic function and blood sugar regulation. Its stable, small-molecule structure provides consistent results, allowing researchers to conduct precise, long-term studies.
Scientists investigate Orforglipron for its interaction with GLP-1 receptors—key regulators of appetite, energy balance, and insulin activity. Because it acts on these pathways without relying on peptide-based systems, it helps expand understanding of non-peptide approaches in metabolic research.
Its dependable structure and oral design support clear data collection and reliable performance across extended studies, making Orforglipron a valuable tool for examining metabolic control and receptor function.
| Size |
1MG (1000MCG) ,2MG (2000MCG) |
|---|
Related products
NeuroboliX Dissolving Strips
NeuroboliX Focus and Energy Dissolving Strips support research on cognitive function, energy utilization, and metabolic pathways. The formula combines Tesofensine and 5-Amino-1MQ, allowing studies to explore how this pairing may influence stamina, focus, and mental clarity, while the fast-dissolving format enables evaluation of sublingual delivery and absorption efficiency.
Reviews
There are no reviews yet.